ScholarLens Back to search
2008•Shanxi Yike Daxue xuebaoRequires access

Diagnostic value of combined detection of CYFRA21-1,CEA and NSE in patients with lung cancer

Yang Jian-yong

Open publisher page 0 citations

Abstract

Objective To explore the value of combined detection of CYFRA21-1,CEA and NSE in diagnosis of lung cancer.Methods The serum levels of CYFRA21-1,CEA and NSE were determined by radioimmunoassay in 65 patients with lung cancer,50 patients with benign pulmonary disease and 38 normal controls.Results The levels of serum CYFRA21-1,CEA and NSE in lung cancer patients were significantly higher than that in patients with benign pulmonary disease and controls(P0.01).The CYFRA21-1,NSE had significant difference in different pathological types of lung cancer.The sensitivity of combined detection was significantly higher than that of single detection.Conclusion The results indicate that the combined detection of CYFRA21-1,CEA and NSE can increase the diagnostic sensitivity of lung cancer,and distinguish the different pathological types of lung cancer.

About this research paper

What this paper is about

Objective To explore the value of combined detection of CYFRA21-1,CEA and NSE in diagnosis of lung cancer.Methods The serum levels of CYFRA21-1,CEA and NSE were determined by radioimmunoassay in 65 patients with lung cancer,50 patients with benign pulmonary disease and 38 normal controls.Results The levels of serum CYFRA21-1,CEA and NSE in lung cancer patients were significantly higher than that in patients with benign pulmonary disease and controls(P0.01).The CYFRA21-1,NSE had significant difference in different pathological types of lung cancer.The sensitivity of combined detection was significantly higher than that of single detection.Conclusion The results indicate that the combined detection of CYFRA21-1,CEA and NSE can increase the diagnostic sensitivity of lung cancer,and distinguish the different pathological types of lung cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To explore the value of combined detection of CYFRA21-1,CEA and NSE in diagnosis of lung cancer.Methods The serum levels of CYFRA21-1,CEA and NSE were determined by radioimmunoassay in 65 patients with lung cancer,50 patients with benign pulmonary disease and 38 normal controls.Results The levels of serum CYFRA21-1,CEA and NSE in lung cancer patients were significantly higher than that in patients with benign pulmonary disease and controls(P0.01).The CYFRA21-1,NSE had significant difference in different pathological types of lung cancer.The sensitivity of combined detection was significantly higher than that of single detection.Conclusion The results indicate that the combined detection of CYFRA21-1,CEA and NSE can increase the diagnostic sensitivity of lung cancer,and distinguish the different pathological types of lung cancer.

Key concepts: Lung cancer, Medicine, Pathological, Lung, Internal medicine, Radioimmunoassay, Cancer, Lung disease

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Diagnostic value of combined detection of CYFRA21-1,CEA and NSE in patients with lung cancer — Research Paper | ScholarLens